Curiox Biosystems
Biotechnology ResearchCentral Region, Singapore51-200 Employees
Curiox Biosystems develops automated workflows for preparing suspension cell samples used in research and clinical diagnostics. Its technology aims to replace conventional centrifugation with gentle processing to preserve cell integrity, improving viability and consistency of results. By reducing manual steps, the systems streamline lab workflows and enhance throughput. Based in Singapore's Central Region, the company operates in the biotechnology research sector and has been listed on Korea's KOSDAQ exchange since 2023. In 2026 it announced software updates for its Pluto Workstation to automate flow cytometry sample preparation from antibody vial to flow-ready sample without coding.